GSK_Annual_Report_2021

Statutory Reports GlaxoSmithKline Pharmaceuticals Limited 50 (b) Details of CSR amount spent in the financial year for ongoing projects of the preceding financial year(s): (1) (2) (3) (4) (5) (6) (7) (8) (9) Sl. No. Project ID. Name of the Project Financial Year in which the project was commenced Project Duration** (In Years) Total Amount allocated for the project (in ` Lakh) Amount spent on the project in the reporting financial year (in ` Lakh) Cumulative amount spent at the end of reporting financial Year (in ` Lakh) Status of the project – Completed/ Ongoing 1 Project Concern International Integration of Morbidity Management and Disability Prevention with public health system FY 19-20 3 399.00 100.00 221.00 Ongoing 2 Society for Nutrition, Education and Health Action Addressing child nutrition through a holistic approach FY 19-20 2 201.00 122.00 186.68 Ongoing 4 Bal Raksha Bharat (Save the Children) WASH facilities in schools with behaviour change communication FY 19-20 2 157.00 85.00 137.00 Ongoing TOTAL 757.00 307.00 544.68 ** Note: Project duration is not linked with the financial year 9. In case of creation or acquisition of capital asset, furnish the details relating to the asset so created or acquired through CSR spent in the financial year (asset-wise details). a. Date of creation or acquisition of the capital asset(s). Not Applicable b. Amount of CSR spent for creation or acquisition of capital asset Not Applicable c. Details of the entity or public authority or beneficiary under whose name such capital asset is registered, their address, etc. Not Applicable d. Provide details of the capital asset(s) created or acquired (including complete address and location of the capital asset). Not Applicable 11. Specify the reason(s), if the company has failed to spend two per cent of the average net profit as per section 135(5): Not Applicable CSR committee responsibility statement Your CSR committee confirms that the implementation and monitoring of CSR Policy is compliant with CSR objectives and policy of your company. S. Venkatesh A. N. Roy Mumbai, 18 May 2021 Managing Director Chairman, CSR Committee